Search - tctmd.com

Displaying 21 - 40 of 151

Sort: Relevancy | Date

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

Presenter: Jean-Claude Laborde, Eric Van Belle, Saif Anwaruddin

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

Presenter: Jean-Claude Laborde, Eric Van Belle, Tomohiko Taniguchi, MD

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Presenter: Mackram F. Eleid

October 30, 2017

Presentation TCT 2017

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Presenter: Howard C. Herrmann

October 30, 2017

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Presentation TCT 2017

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Presenter: Danny Dvir

October 30, 2017

Presentation TCT 2017

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Presenter: John G. Webb

October 30, 2017

Presentation TCT 2017

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

Presenter: Vinayak Bapat

October 30, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Advertisement

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

The NOTION 2 Low-risk Trial in Younger Patients

The Evolut R Low-risk Trial

The PARTNER 3 Low-risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content